M. KESKİNKILIÇ Et Al. , "Increased Blood Creatinine Level due to CDK 4/6 Inhibitor Treatments: Single Center Experience ," Esmo Breast Congress 2022 , vol.33, Berlin, Germany, pp.216, 2022
KESKİNKILIÇ, M. Et Al. 2022. Increased Blood Creatinine Level due to CDK 4/6 Inhibitor Treatments: Single Center Experience . Esmo Breast Congress 2022 , (Berlin, Germany), 216.
KESKİNKILIÇ, M., SEMİZ, H. S., YAVUZŞEN, T., & KARAOĞLU, A., (2022). Increased Blood Creatinine Level due to CDK 4/6 Inhibitor Treatments: Single Center Experience . Esmo Breast Congress 2022 (pp.216). Berlin, Germany
KESKİNKILIÇ, MERVE Et Al. "Increased Blood Creatinine Level due to CDK 4/6 Inhibitor Treatments: Single Center Experience ," Esmo Breast Congress 2022, Berlin, Germany, 2022
KESKİNKILIÇ, MERVE Et Al. "Increased Blood Creatinine Level due to CDK 4/6 Inhibitor Treatments: Single Center Experience ." Esmo Breast Congress 2022 , Berlin, Germany, pp.216, 2022
KESKİNKILIÇ, M. Et Al. (2022) . "Increased Blood Creatinine Level due to CDK 4/6 Inhibitor Treatments: Single Center Experience ." Esmo Breast Congress 2022 , Berlin, Germany, p.216.
@conferencepaper{conferencepaper, author={MERVE KESKİNKILIÇ Et Al. }, title={Increased Blood Creatinine Level due to CDK 4/6 Inhibitor Treatments: Single Center Experience }, congress name={Esmo Breast Congress 2022}, city={Berlin}, country={Germany}, year={2022}, pages={216} }